com)-- Innovation in the Prefilled Syringe Market Biologics and Autoinjection Devices Shaping Future R&D Trends
GBI Research, the leading business intelligence provider, has released its latest research, Innovation in the Prefilled Syringe Market Biologics and Autoinjection Devices Shaping Future R&D Trends, which provides insights into possible future avenues of R&D in the prefilled syringe market.
The market for prefilled syringes is being driven by the rise in popularity of autoinjection devices for the home-use market.
today announced the availability of Betaject(R) 3, a new autoinjection device specifically designed to work with Betaseron(R) (interferon beta-1b) as an optional injection method for patients with relapsing forms of multiple sclerosis (MS).
The Betaject 3 autoinjection device is the latest innovation designed to assist patients on Betaseron treatment.
A fluoropolymer-silicone liner sits atop the vials, sealing them but allowing needle penetration in autoinjection
When ICI is used, it is important that patients are treated by specialists who are familiar with this type of treatment, are willing to take the time for detailed patient education on autoinjection, and are available for routine follow-up examinations (Zentgraf, Ludwig & Ziegler, 1989).
Impotence: treatment by autoinjection of vasoactive drugs.
com/research/6b2nzg/innovation_in_the) has announced the addition of the "Innovation in the Prefilled Syringe Market - Biologics and Autoinjection
Devices Shaping Future R&D Trends" report to their offering.
The Rebiject II(TM) autoinjection
device was designed to provide greater comfort, convenience and safety, and the new 29-gauge needle -- the thinnest needle available for any MS therapy -- was developed to reduce injection pain and injection site reactions.
Plans include emphasizing products for evaluating safety and quality in an array of medical devices ranging from catheter systems to autoinjection